Growth Metrics

Opus Genetics (IRD) EPS (Basic) Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 139.68%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 25.99%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 41.58%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 14.28%
7 Evaxion A 62.56 Bn 62.54 Bn - 58.35%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -2.92%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 45.92%
10 Opus Genetics 357.99 Mn 298.03 Mn - -38.88%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -38.88%
Dec 31, 2025 -28.51%
Sep 30, 2025 -4.35%
Jun 30, 2025 21.70%
Mar 31, 2025 11.82%
Dec 31, 2024 -91.80%
Sep 30, 2024 -5.07%
Jun 30, 2024 16.75%
Mar 31, 2024 56.69%
Dec 31, 2023 61.47%
Sep 30, 2023 40.74%
Jun 30, 2023 17.67%
Mar 31, 2023 31.47%
Dec 31, 2022 79.90%
Sep 30, 2022 23.43%
Jun 30, 2022 25.72%
Mar 31, 2022 17.35%
Dec 31, 2021 -25.99%
Sep 30, 2021 50.17%
Jun 30, 2021 28.95%
Mar 31, 2021 -65.33%
Dec 31, 2020 -212.72%
Sep 30, 2020 -102.06%
Jun 30, 2020 -133.62%
Mar 31, 2020 1.49%
Dec 31, 2019 -182.31%
Sep 30, 2019 -55.63%
Jun 30, 2019 -96.82%
Mar 31, 2019 -45.81%
Dec 31, 2018 -65.10%
Sep 30, 2018 -365.70%
Jun 30, 2018 -316.98%
Mar 31, 2018 -240.56%
Dec 31, 2017 -128.94%
Sep 30, 2017 -58.74%
Jun 30, 2017 42.22%
Mar 31, 2017 -116.24%
Dec 31, 2016 -25.99%
Sep 30, 2016 -86.63%
Jun 30, 2016 -38.67%
Mar 31, 2016 -171.44%
Dec 31, 2015 -98.47%
Sep 30, 2015 12.64%
Jun 30, 2015 -25.99%
Mar 31, 2015 0.00%
Dec 31, 2014 -44.22%
Sep 30, 2014 20.63%
Jun 30, 2014 30.68%
Mar 31, 2014 -21.64%
Dec 31, 2013 30.66%
Sep 30, 2013 -108.23%
Jun 30, 2013 15.66%